Effects of infectious complications on patients' survival in peritoneal dialysis

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 8, 2013, Pages 1064-1072

  Sinangil, A ^a   Koc, Y ^a   Unsal, A ^a   Basturk, T ^a   Sakaci, T ^a   Ahbap, E ^a   Budak, S K ^a   Doner, B ^a   Sevinc, M ^a  

^a Sisli Etfal Research and Educational Hospital   (Turkey)

Author keywords

Catheter exit site infection; Mortality; Peritoneal dialysis; Peritonitis

Indexed keywords

ADULT; APPLICATION SITE INFECTION; ARTICLE; CHRONIC GLOMERULONEPHRITIS; DIABETIC NEPHROPATHY; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; INFECTIOUS COMPLICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PERITONITIS; RETROSPECTIVE STUDY; SOCIAL STATUS; SURVIVAL; SURVIVAL TIME; TREATMENT DURATION; TREATMENT WITHDRAWAL; TUBERCULOSIS;

ADULT; AGED; BACTERIAL INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SURVIVAL RATE;

EID: 84878597106     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. SHIH YC, GUO A, JUST PM, MUJAIS S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int 2005: 68: 319-329.
2. GOKAL R, FIGUERAS M, OLLE A, ROVIRA J, BADIA X. Outcomes in peritoneal dialysis and haemodialysis-a comparative assessment of survival and quality of life. Nephrol Dial Transplant 1999: 14(Suppl 6): 24-30.
3. HEAF JG, LOKKEGAARD H, MADSEN M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002: 17; 112-117.
4. KIM DK, YOO TH, RYU DR, XU ZG, KIM HJ, CHOI KH, LEE HY, HAN DS, KANG SW. Change in causative organizms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004: 24; 424-432.
5. KAM-TAO LI P, SZETO C, PIRAINO B, BERNARDINI J, FIGUEIREDO AE, GUPTA A, JOHNSON DW, KUIJPER EJ, LYE WC, SALZER W, SCHAEFER F, STRUIJK DG; INTERNATIONAL SOCIETY FOR PERITONEAL DIALYSIS. Peritoneal dialysis-related infections recommendations. 2010 Uptake. Perit Dial Int 2010; 30: 393-423.
6. HAN SH, LEE SC, AHN SV, LEE JE, CHOI HY, KIM BS, KANG SW, CHOI KH, HAN DS, LEE HY. Improving outcome of CAPD:twenty-five years' experience in a single Korean center. Perit Dial Int 2007; 27: 432-440.
7. LAI KN, LO WK. Optimal peritoneal dialysis for patients from Hong Kong. Perit Dial Int 1999; 19(Suppl 3): 26-31.
8. LO WK, JIANG Y, CHENG SW, CHENG IKP. Survival of CAPD patients in a center using three two-liter exchanges as standard regime. Perit Dial Int 1996; 16(Suppl 1): 163-166.
9. SIPAHIOGLU MH, AYBAL A, UNAL A, TOKGOZ B, OYMAK O, UTAS C. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years' experience in a single center. Perit Dial Int 2008; 28: 238-245.
10. GAMBA G, MEJIA JL, SALDIVAR S, PENA JC, CORREA-ROTTER R. Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 1993; 65: 23-27.
11. CUETO-MANZANO AM, QUINTANA-PINA E, CORREA-ROTTER R. Long-term CAPD survival and analysis of mortality risk factors: 12 year experience of a single Mexican center. Perit Dial Int 2001; 21: 148-153.
12. AVRAM MM, MITTMAN N, BONOMINI L, CHATTOPADHYAY J, FEIN P. Markers for survival in dialysis: A sevenyear prospective study. Am J Kidney Dis 1995; 26: 209-219.
13. COLLINS AJ, HAO W, XIA H, EBBEN JP, EVERSON SE, CONSTANTINI EG, MA JZ. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065-1074.
14. CHURCHILL DN, THORPE KE, NOLPH KD, KESHAVIAH PR, OREOPOULOS DG, PAGE D. Increased peritoneal membrane transpor t is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: 1285-1292.
15. JOHNSON JG, GORE SM, FIRTH J. The effect of age, diabetes, and other comorbidity on the survival of patients on dialysis: A systematic quantitative overview of the literature. Nephrol Dial Transplant 1999; 14: 2156-2164.
16. SANTOIANNI JE, PREDARI SC, VERON D, ZUCCHINI A, DE PAULIS AN. A 15 year-review of peritoneal dialysis-related peritonitis: Microbiological trends and patterns of infection in a teaching hospital in Argentina. Rev Argentina Microbiol 2008; 40: 17-23.
17. HUANG JW, HUNG KJ, YEN CJ, WU KD, TSAI TJ. Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis. Nephrol Dial Transplant 2001; 16: 604-607.
18. PREDARI SC, ABALO AB, SANTOIANNI JE, PRADO A, RIBAS MC, ZUCCHINI A. Peritonitis en diálisis peritoneal continua ambulatoria. Evaluación microbiológica y clínica. Medicina 1990; 50: 102-106.
19. STRIPPOLI GF, TONG A, JOHNSON D, SCHENA FP, CRAIG JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol 2004; 15: 2735-2746.
20. TROIDLE L, FINKELSTEIN F. Treatment and outcome of CPD associated peritonitis. Ann Clin Microbiol Antimicrob 2006; 5: 6.
21. TZAMALOUKAS MI. Decreasing morbidity and mortality in long term peritoneal dialysis patients. Semin Dial 1995; 8: 397-400.
22. POBBOCK CA, IBEBS LS, CATERSON RJ, MAHONEY JF, WAUGH DA, COCKSEDGE B. Continuous ambulatory peritoneal dialysis-Eight years of experience at a single center. Medicine (Baltimore) 1989: 68: 293-308.
23. RUBIN J, HSU H. Continuous ambulatory peritoneal dialysis: ten years at one facility. Am J Kidney Dis 1991; 17: 165-169.
24. FONTAN PM, CARMONA RA, GARCIA-NAVEIRO R, ROSALES M, VILLAVERDE P, VALDES F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25: 274-284.
25. FRIED LF, BERNARDINI J, JOHNSTON JR, PIRAINO B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176-2182.
26. LAMEIRE N, VAN BIESEN W, VANHOLDER R. The role of peritoneal dialysis as first modality in an integrative approach to patients with end-stage renal disease. Perit Dial Int 2000: 20(Suppl 2): 134-141.
27. LOBBEDEZ T, CRAND A, LE ROY F, LANDRU I, QUERE C, RYCKELYNCK JP. Transfer from chronic haemodialysis to peritoneal dialysis. Nephrol Ther 2005; 1: 38-43.
28. FIRANEK CA, VONESH EF, KORBERT SM. Patient and technique survival among an urban population of peritoneal dialysis patients: An 8 year experience. Am J Kidney Dis 1991; 18: 91-96.
29. LUPO A, TARCHINI R, CANCARINI G, CATIZONE L, COCCHI R, DE VECCHI A, VIGLINO G, SALOMONE M, SEGOLONI G, GIANGRANDE A. Long-term outcome in continuous ambulatory peritoneal dialysis: a 10 year survey by the Italian Cooperative Peritoneal Dialysis Study Group. Am J Kidney Dis 1994: 24: 826-837.
30. ASLAM N, BERNARDINI J, FRIED L, BURR R, PIRAINO B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 2006; 1: 1226-1233.
31. CHOW KM, SZETO CC, LEUNG CB, LAW MC, LI PKT. Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 2005; 20: 2504-2510.
32. CHOW KM, SZETO CC, LEUNG CB, KWAN BC, LAW MC, LI PK. A risk analysis of continuous ambulatory peritoneal dialysis-related peritonitis. Perit Dial Int 2005; 25: 374-379.
33. CARAMORI, JCT. Peritonites em pacientes tratados com diálise peritoneal ambulatorial contínua: estudo clínico e microbiológico [tese de doutorado]. São Paulo:Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, 1999.
34. LOBO JV, VILLAR KR, ANDRADE JÚNIOR MP, BASTOS KA. Predictor factors of peritoneal dialysis-related peritonitis. J Bras Nefrol 2010; 32: 156-164.
35. MORAES TP, PECOITS-FILHO R, RIBEIRO SC, RIGO M, SILVA MM, TEIXEIRA PS, PASQUAL DD, FUERBRINGER R, RIELLA MC. Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int 2009; 29: 492-498.
36. LIMA RC, BARREIRA A, CARDOSO FL, LIMA MHS, LEITE JR M. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five year follow-up. Perit Dial Int 2007; 27: 56-60.
37. BARRETTI P, BASTOS KA, DOMINGUEZ J, CARAMORI JCT. Peritonitis in Latin America. Perit Dial Int 2007; 27: 332-339.
38. TZAMALOUKAS AH, OBERMILLER LE, GIBEL LJ, MURATA GH, WOOD B, SIMON D, ERICKSON DG, KANIG SP. Per itonitis associated with intraabdominal pathology in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1993; 13(Suppl 2): 335-337.
39. KERN EO, NEWMAN LN, CACHO CP, SCHULAK JA, WEISS MF. Abdominal catastrophe revisited: the risk and outcome of enteral peritoneal contamination. Perit Dial Int 2002; 22: 323-334.
40. GOLDIE SJ, KIERNAN-TROIDLE L, TORRES C, GORBANBRENNAN N, DUNNE D, KLIGER AS, FINKELSTEIN FO. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996; 28: 86-91.
41. WANG AY, YU AW, LI PK, LAM PK, LEUNG CB, LAI KN, LUI SF. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9 year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183-1192.
42. BUNKE CM, BRIER ME, GOLPER TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52: 524-529.
43. TROIDLE L, GORBAN-BRENNAN N, KLIGER A, FINKELSTEIN F. Differing outcomes of gram-positive and gramnegative peritonitis. Am J Kidney Dis 1998; 32: 623-628.
44. PEACOCK SJ, HOWE PA, DAY NP, CROOK DW, WINEARLS CG, BERENDT A. Outcome following staphylococcal peritonitis. Perit Dial Int 2000; 20: 215-219.
45. MUJAIS S, STORY K. Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts. Kidney Int 2006; 70: 21-26.
46. VONESH EF, SNYDER JJ, FOLEY RN, COLLINS AJ. Mortality studies comparing peritoneal dialysis and hemodialysis: What do they tell us? Kidney Int 2006; 70: 3-11.
47. LOPES AA, BRAGG-GRESHAM JL, GOODKIN DA FUKUHARA S, MAPES DL, YOUNG EW, GILLESPIE BW, AKIZAWA T, GREENWOOD RN, ANDREUCCI VE, AKIBA T, HELD PJ, PORT FK. Factors associated with health-related quality of life among hemodialysis patients in the DOPPS. Qual Life Res 2007; 16: 545-557.
48. NOLPH KD, CUTLER SJ, STEINBERG SM, NOVAK JW, HIRSHMAN GH. Factors associated with morbidity and mortality among patients on CAPD. ASAIO (Am Soc Artif Intern Organs) Trans 1987; 33: 54-65.
49. NISSENSON AR, GENTILE DE, SODERBBOM RE, OLIVER DF, BRAX C, THE MEDICAL REVIEW BOARD LOS ANGELES, CALIFORNIA. Morbidity and mortality of continuous ambulatory peritoneal dialysis: regional expenience and bong-term prospects. Am J Kidney Dis 1986; 7: 229-234